MONDAY, Nov. 27, 2023 (HealthDay Information) — COVID-19 vaccination earlier than an infection is related to a decreased danger for post-COVID-19-condition (PCC), in accordance with a examine revealed on-line Nov. 22 in The BMJ.
Lisa Lundberg-Morris, from the College of Gothenburg in Sweden, and colleagues performed a population-based cohort examine to look at the effectiveness of main COVID-19 vaccination (first two doses and first booster dose) in opposition to PCC. Information have been included for all 589,722 adults with COVID-19 first registered between Dec. 27, 2020, and Feb. 9, 2022, within the two largest areas of Sweden.
Of the vaccinated people, 21,111; 205,650; and 72,931 acquired one two, and three or extra doses, respectively. The researchers discovered that 0.4 p.c of 299,692 vaccinated people with COVID-19 had a analysis of PCC throughout follow-up in contrast with 1.4 p.c of 290,030 unvaccinated people. There was an affiliation between COVID-19 vaccination with any variety of doses earlier than an infection and a decreased danger for PCC (adjusted hazard ratio, 0.42), with vaccine effectiveness of 58 p.c. Vaccine effectiveness was 21, 59, and 73 p.c with one, two, and three or extra doses, respectively.
“The outcomes from this examine spotlight the significance of full main vaccination protection in opposition to COVID-19, not solely to cut back the danger of extreme acute COVID-19 an infection but in addition the burden of PCC within the inhabitants,” the authors write.
A number of authors disclosed ties to the pharmaceutical business.
Discover more from PressNewsAgency
Subscribe to get the latest posts sent to your email.